Derive and validate DID for staggered rollout

Imagine randomization is not an option and you have to rely on staggered adoption across EU regions. (a) Write down the two-period/two-group Difference-in-Differences (DiD) estimator, then extend it to multiple periods with staggered treatment. (b) Explain why two-way fixed effects (TWFE) can produce biased ATT estimates when treatment timing or effects are heterogeneous (negative weights). (c) Suggest an estimator that fixes this (for example, Sun–Abraham or Callaway–Sant’Anna), state the estimand you want to recover, and outline an event-study specification plus pre-trend tests. (d) Describe the identifying assumptions (parallel trends, no anticipation), diagnostics (placebos, lead/lag checks), standard-error choices (cluster-robust by region, wild bootstrap when there are few clusters), and how you would deal with treatment reversal or partial adoption. Finish by explaining how you would communicate the ATT and uncertainty to executives.

Overview: This question tests a data scientist's ability in causal inference and panel-data methods—specifically Difference-in-Differences with staggered adoption, treatment-effect identification, event-study analysis, and robust inference when randomized designs are not possible—and is often used to evaluate reasoning about sources of bias, heterogeneous timing, and assumption-driven diagnostics in policy evaluation. Category: Statistics & Math; level of abstraction: both conceptual understanding and practical application, since it covers estimand definition and limitations (including biases from two-way fixed effects and weighting), selection of appropriate estimators and diagnostics, inference choices (clustered standard errors and small-cluster methods), and clear communication of ATT and uncertainty to stakeholders; English summary.